478 related articles for article (PubMed ID: 19220503)
21. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
Dahlöf CG; Pascual J; Dodick DW; Dowson AJ
Cephalalgia; 2006 Apr; 26(4):400-8. PubMed ID: 16556240
[TBL] [Abstract][Full Text] [Related]
22. The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the "Act when mild" study.
Díaz-Insa S; Goadsby PJ; Zanchin G; Fortea J; Falqués M; Vila C
Int J Neurosci; 2011 Dec; 121(12):655-61. PubMed ID: 21777163
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
[TBL] [Abstract][Full Text] [Related]
24. Early treatment of migraine with rizatriptan: a placebo-controlled study.
Mathew NT; Kailasam J; Meadors L
Headache; 2004; 44(7):669-73. PubMed ID: 15209688
[TBL] [Abstract][Full Text] [Related]
25. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
Martin V; Cady R; Mauskop A; Seidman LS; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2008 Feb; 48(2):226-35. PubMed ID: 18005144
[TBL] [Abstract][Full Text] [Related]
27. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.
Burstein R; Collins B; Jakubowski M
Ann Neurol; 2004 Jan; 55(1):19-26. PubMed ID: 14705108
[TBL] [Abstract][Full Text] [Related]
28. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
Sandrini G; Dahlöf CG; Mathew N; Nappi G
Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092
[TBL] [Abstract][Full Text] [Related]
29. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.
Spierings EL; Keywood C
Pain Med; 2009; 10(4):633-8. PubMed ID: 19453958
[TBL] [Abstract][Full Text] [Related]
30. Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
Diener HC
Headache; 2005 Jun; 45(6):624-31. PubMed ID: 15953293
[TBL] [Abstract][Full Text] [Related]
31. Migraine treatment with rizatriptan and almotriptan: a crossover study.
Ng-Mak DS; Hu XH; Bigal M
Headache; 2009 May; 49(5):655-62. PubMed ID: 19456878
[TBL] [Abstract][Full Text] [Related]
32. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
[TBL] [Abstract][Full Text] [Related]
33. Almotriptan: a review of pharmacology, clinical efficacy, and tolerability.
Von S
Am J Manag Care; 2002 Feb; 8(3 Suppl):S74-9. PubMed ID: 11859907
[TBL] [Abstract][Full Text] [Related]
34. Early triptan intervention in migraine: an overview.
Moschiano F; D'Amico D; Allais G; Rigamonti A; Melzi P; Schieroni F; Bussone G
Neurol Sci; 2005 May; 26 Suppl 2():s108-10. PubMed ID: 15926006
[TBL] [Abstract][Full Text] [Related]
35. Does early migraine treatment shorten time to headache peak and reduce its severity?
Hu XH; Ng-Mak D; Cady R
Headache; 2008 Jun; 48(6):914-20. PubMed ID: 18005142
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
Silberstein SD; Cady RK; Sheftell FD; Almas M; Parsons B; Albert KS
Headache; 2007 May; 47(5):673-82. PubMed ID: 17501848
[TBL] [Abstract][Full Text] [Related]
37. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
Linde M; Mellberg A; Dahlöf C
Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
[TBL] [Abstract][Full Text] [Related]
38. Zolmitriptan provides effective migraine relief in adolescents.
Linder SL; Dowson AJ
Int J Clin Pract; 2000 Sep; 54(7):466-9. PubMed ID: 11070573
[TBL] [Abstract][Full Text] [Related]
39. Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study.
Leone M; Vila C; McGown C
Expert Rev Neurother; 2010 Sep; 10(9):1399-408. PubMed ID: 20819011
[TBL] [Abstract][Full Text] [Related]
40. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
Goldstein J; Tiseo PT; Albert KS; Li C; Sikes CR
Headache; 2006; 46(7):1142-50. PubMed ID: 16866718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
